Stendra Approval History

  • FDA approved: Yes (First approved April 27th, 2012)
  • Brand name: Stendra
  • Generic name: avanafil
  • Company: Vivus, Inc.
  • Treatment for: Erectile Dysfunction

Stendra (avanafil) is a phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED).

FDA Approval History for Stendra

DateArticle
Apr 27, 2012Approval FDA Approves Stendra for Erectile Dysfunction
Sep  2, 2011VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction
Jun 30, 2011VIVUS Submits New Drug Application for Avanafil for the Treatment of Erectile Dysfunction

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web1)